ARK Investment Management - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$42,527,968
-83.7%
4,214,863
-63.8%
0.37%
-79.7%
Q3 2022$261,207,000
-1.4%
11,655,833
+1.6%
1.82%
+16.2%
Q2 2022$265,041,000
-37.8%
11,473,655
+4.4%
1.57%
-11.9%
Q1 2022$426,012,000
-29.4%
10,988,182
+6.6%
1.78%
-2.5%
Q4 2021$603,365,000
-6.6%
10,312,167
-5.4%
1.82%
+17.5%
Q3 2021$646,177,000
-0.5%
10,902,258
+45.7%
1.55%
+28.4%
Q2 2021$649,458,000
+20.2%
7,483,102
+14.2%
1.21%
+12.7%
Q1 2021$540,422,000
+104.8%
6,554,546
+125.9%
1.07%
+52.8%
Q4 2020$263,852,000
+358.4%
2,901,700
+101.5%
0.70%
+105.9%
Q3 2020$57,556,000
+64.5%
1,439,970
+41.2%
0.34%
-9.3%
Q2 2020$34,990,000
+183.8%
1,019,830
+83.7%
0.38%
+22.5%
Q1 2020$12,328,000
+46.1%
555,082
+28.8%
0.31%
+44.1%
Q4 2019$8,437,000
+60.2%
431,128
+27.2%
0.21%
+85.2%
Q3 2019$5,265,000
+16.8%
339,039
+52.7%
0.12%
+0.9%
Q2 2019$4,508,000222,0640.11%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$197,709,00022.51%
Redmile Group, LLC 12,957,222$758,127,00017.24%
Grosvenor Holdings, L.L.C. 1,037,256$60,690,0006.28%
Casdin Capital, LLC 3,400,000$198,934,0005.61%
Ally Bridge Group (NY) LLC 270,000$15,798,0005.52%
DAFNA Capital Management LLC 372,160$21,775,0005.48%
Tri Locum Partners LP 142,032$8,310,0003.27%
Kynam Capital Management, LP 95,561$5,591,0002.99%
Artal Group S.A. 1,800,000$105,318,0002.86%
Bellevue Group AG 3,775,736$220,918,0002.28%
View complete list of FATE THERAPEUTICS INC shareholders